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In vivo 31p magnetic resonance spectroscopy and
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Summary The relationship between the bioenergetic status of human glioma xenografts in nude mice and morphometric parameters of the
perfused vascular architecture was studied using 31p magnetic resonance spectroscopy (MRS), fluorescence microscopy and two-
dimensional digital image analysis. Two tumour lines with a different vascular architecture were used for this study. Intervascular distances
and non-perfused area fractions varied greatly between tumours of the same line and tumours of different lines. The inorganic
phosphate-nucleoside triphosphate (Pi/NTP) ratio increased rapidly as mean intervascular distances increased from 100 gm to 300 ,um. Two
morphometric parameters - the percentage of intervascular distances larger than 200 gm (ivd200) and the non-perfused area fraction at a
distance larger than 100 ,um from a nearest perfused vessel (areal0o), - were deduced from these experiments and related to the P/NTP ratio
of the whole tumour. It is assumed that an aerobic to anaerobic transition influences the bioenergetic status, i.e. the Pi/NTP ratio increased
linearly with the percentage of ivd200 and the area100.
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Phosphorus magnetic resonance spectroscopy (31P-MRS) studies
ofthe bioenergetic status of tumours have been compared directly
with tumour tissue po2 (Vaupel et al, 1989a) and with several
physiological parameters that affectpO2 in tumour tissue, such as
the intravascular concentration of oxyhaemoglobin (Rofstad et al,
1988) and tumour blood perfusion (Evelhoch et al, 1986). 31P-
MRS has been demonstrated to be sensitive to tumour size
(Okunieff et al, 1986; Wendland et al, 1992), with an increase in
tumour size being supposed to have a negative influence on perfu-
sion- and diffusion-limited oxygen delivery and nutrient delivery
(Vaupel, 1996). The global bioenergetic status of a tumour,
expressed as the P/NTP ratio, depends on the balance between the
oxygen and nutrient supply, and the consumption rates of the
tumour cells, which is related to the type of energy metabolism.
This balance between supply and consumption determines the crit-
ical diffusion distances for oxygen and nutrients in tumour tissue.
The total oxygen supply and nutrient supply depends on the
tumour microcirculation and on the diffusion geometry.
The purpose of this study was to investigate the existence of a
possible relationship between the global bioenergetic status and
the diffusion geometry of human glioma xenografts in nude mice.
A two-dimensional morphometric analysis of the perfused
vascular architecture of complete transverse tumour sections was
performed. Morphometric parameters, such as the percentage of
large intervascular distances and the fraction ofnon-perfused areas
in a tumour section area, are related to the diffusion-limited
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oxygen delivery and nutrient delivery. Critical diffusion distances
for oxygen and nutrients per perfused vessel can be estimated
using a Krogh model (Vaupel, 1974; Kreuzer, 1982; Kallinowski
et al, 1987; Groebe et al, 1988; Vaupel et al, 1989b; Dewhirst et al,
1994). For example, the mean critical oxygen diffusion distance in
gliomas using a Krogh model is approximately 100 im. When
tumour cells have an aerobic energy metabolism, changes in the
percentage of intervascular distances larger than approximately
200 ,um are expected to affect the global bioenergetic status
(PI/NTP ratio). This indeed was observed. In addition, the mean
fraction of the non-perfused tumour area at a distance larger than
approximately 100 ,um from the edge of the nearest perfused
vessel was also found to be related to the global bioenergetic status
of a tumour.
MATERIALS AND METHODS
Animal model
Two tumour lines (E49, n = 14; E98, n = 10), derived from two
different primary human gliomas, were grown subcutaneously in
the hind limb of athymic mice (Balb/c nu/nu, BonholdGard,
Denmark) after several passages in the flank ofnude mice. During
the 31P-MRS experiments, motion artefacts were less important for
tumours on the hind limb than fortumours on the flank. The exper-
imental procedures were approved by the local ethics committee
for animal use.
In vivo 31p magnetic resonance spectroscopy
MRS measurements were performed on a vertical-bore Bruker
spectrometer (4.7 T) using a home-built 'H/3'P double-tunable
three-tum solenoid coil with an inner diameter of 13 mm. The
solenoid coil was fitted with a Faraday shield to eliminate spurious
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Figure 1 Matched digital images of a scanned tumour section at the centre of an E49 tumour no. 4 (A) and E98 no. 15 (C) with the corresponding 31P-MR
spectra of the whole tumour (B and D). The perfused vessel structures are situated in a vessel domain delineated by the lines. Peak assignments of 31P-MR
spectra in B and D: 1, phosphomonoesters; 2, P,; 3, phosphodiesters; 4, PCr; 5, y-phosphate of NTP; 6, a-phosphate of NTP; 7, ,-phosphate of NTP
signals from normal tissue adjacent to the tumour. Mice with
human glioma xenografts were excluded if host tissue was
partially present in the volume sampled by the solenoid (tumour
weight < 0.3 g) and when tumours were too large to fit completely
in the solenoid (tumour weight > 0.9 g).
The mice were anaesthetized with a flow of 1.5% enflurane in
an oxygen-nitrous oxide (3:7) mixture applied through a nose
cone. Body temperature was monitored by a rectal probe
(36-gauge wire, Hewlett Packard) and maintained at 36.5-37°C by
a warm-water blanket with a feedback system. 31P-MR spectra
were obtained with a one-pulse sequence with a hard pulse of
12 js (optimized for maximum signal intensity) and a pulse
repetition time of 5 s. The number of scans was 320.
As the 3'P-MRS experiments were carried out with an interpulse
delay shorter than three times the T, of the 3'P spins of the Pi (i.e.
approximately 4 s), the area of the P, peak is not strictly propor-
tional to its concentration (Certaines et al, 1993). However, all in
vivo spectra were run with the same acquisition parameters and in
this group oftumours little effect is expected on the calculations of
the P./NTP ratio at a pulse repetition time of5 s.
Fluorescence microscopy
After the MRS experiments, 0.05 ml of phosphate-buffered
saline (PBS, pH 7.4) containing a fluorescent perfusion marker,
Hoechst 33342 (15 mg kg-', Sigma, St Louis, MO, USA), was
injected i.v. via a lateral tail vein. One minute after injection, the
mice were killed and tumours were quickly removed and frozen in
liquid nitrogen, preventing the dye from diffusing too far into
tissue. The tumour was cut in two halves: one halfwas used forthe
analysis of the perfused vascular architecture and the other half
was used for classical histological staining with eosin (cytoplasm)
and haematoxylin (nuclei).
Fifteen frozen tissue sections (5 jum) at random locations were
made using a freeze microtome. Sections were processed at room
temperature by a 15-min incubation with collagen type IV poly-
clonal antibody (rabbit serum, Euro-Diagnostics, Oss, The
Netherlands), a marker for the basal lamina ofthe tumour vascula-
ture. Next, the sections were incubated with a second antibody,
goat anti-rabbit immunoglobulin labelled with TRITC (Tago,
Burlingame, CA, USA).
In this paper any vascular structure, including arterioles,
venules and capillaries, in a tumour tissue section stained by
collagen type IV antibody is described as a vessel. The whole-
tumour sections were analysed in the fluorescence microscope
using a digital-image processing system. A detailed description of
this method is given by Rijken et al (1995). Briefly, each section
was scanned twice on the computer-controlled motorized stage of
a fluorescence microscope using two different excitation-emission
filters. After processing all fields ofeach scan, a composite image
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was reconstructed from the individual processed fields, revealing
the perfused vessels (Hoechst image) and the total vascular bed
(collagen image) in separate scans. When both images were
combined, the new matched image showed the perfused and non-
perfused vessels. In the next step, the fluorescent rim of Hoechst
dye around perfused vessels, due to Hoechst diffusion into adja-
cent tissue, was deleted by image processing. In Hoechst images
only, vascular areas are slightly overestimated.
Data analysis
31P-MRspectra
500 600 Zero filling and the convolution difference technique with line
broadenings of 30 and 1000 Hz were applied to the free induction
decay (FID). The peaks of the a, I, y-NTP, P and, when present,
irdistances in phosphocreatine (PCr) were fitted to Lorentzian line shapes with
picted on the y NMR1 software (New Methods Research, Syracuse, NY, USA).
m ivd of no. 13 is The integral of thePi peak and the sum of the integral of the a, 1,
y-NTP peaks were used in the calculation ofthe P./NTP ratio.
Calculation ofthepHm,s
The pH was deduced from the chemical shift of the P, signal
with respect to the chemical shift of the PCr signal, or the a-
NTP signal in the absence of a PCr resonance. A modified
Henderson-Hesselbach equation was used, with the following
parameters: pK 6.75, a (acid shift) = 3.29, b (base shift) = 5.7
(Moon et al, 1973; Seo et al, 1983).
Vascular morphology of perfused vessels
The percentage ofintervascular distances > 200,im(ivd2od
For each perfused vessel, a domain (Yoshii et al, 1988), i.e. the
area oftumour tissue that is supposed to be supplied by the nearest
400 500 600 perfused vessel, was determined in matched images. As a conse-
quence, one domain contains one perfused vascular structure,
and may contain non-perfused vascular structures and avascular
ivd(gim) pertumour for the regions. With the help of an image analysis system, contours of
s one tumour these domains are represented by line networks in Figure 1. The
shortest distance between neighbouring perfused vascular struc-
tures was used as an estimation ofthe ivd. Note that neighbouring
perfused vascular structures have adjacent domains. Thus, inter-
vascular distances were not determined between perfused vascular
structures that did not have adacent domains. Calculations of
distances were started from perfused vessel walls. Ivds obtained
by a domain analysis are always larger than ivds between perfused
vessels, measured in perfused regions only (Less et al, 1991). For
each tumour, the frequency distribution ofthe ivds was determined
for all values calculated in the 15 tumour sections (Statistica,
StatSoft, Tulsa, OK, USA). The percentage of intervascular
distances > 200 gm (ivd200) was obtained from the cumulative
frequency distribution for the whole tumour.
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Figure 4 Plot of the correlation between the P./NTP ratio (
percentage of intervascular distances larger than 200 ,um [
line indicates the results of least-squares linear regression
0.70) of the data for the tumour lines E49 (O), E98 (-): y =
0.01 ± 0.002 x x. The dashed line shows the 95% confider
square represents one tumour. The P./NTP ratio (A) for thi
(skeletal muscle hind limb) is 0.09 ± 0.01 and the percenta
The datapoint of the host tissue was not used in the regres
40 50 The fraction ofthe non-perfused tumourarea ata
distance larger than 100gm from the nearestperfused
vessel(areal.) -) and the In matched images, a circle with a radius of 100 jm was drawn
analysis (iA2 = around every perfused vessel. Foreach tumour section, the tumour
0.18±0.04+ area outside the circles was determined and divided by the total
ice intervals. One tumour section area. Next, a mean non-perfused area fraction at a
e host tissue
ige ofivd200 =0. distance > 100 jim from the nearestperfused vessel was calculated
ssion analysis for all 15 tumour sections.
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The morphological parameter - the percentage of ivd200 - is
probably less sensitive to the total non-perfused area than the
parameter areal1o. Only a few long ivds (> 200 gm) may be
responsible for the determination of a large non-perfused area. In
other words, the weight of a few long ivds in comparison with all
ivds is of less importance than the weight of the non-perfused
areas in relation to the total tumour area.
Analysis of the relationship between the P,/NTP ratio
and the morphometrical parameters
Linear regression analysis was performed between the morphomet-
rical parameters, mentioned above, and the P/NTP ratios using
Graphpad (Graphpad PRISM version 2.0, San Diego, USA). The
goodness ofthe fit(R2), the 95% confidence intervals andtheP-value
of the slope are given, i.e. test result of the significant difference of
the slope from zero. Values presented in the text are means ± s.d.
RESULTS
Comparison of vascular morphometrical analysis of
perfused vessels between the tumour lines (E49, E98)
and host tissue
In Figure 2, a frequency histogram ofthe ivds is given for a single
tumour and host tissue, i.e. skeletal muscle of the hind limb.
Tumour tissue showed an important tail oflong ivds in comparison
with host tissue. Ivds larger than 200gm were not observed in host
tissue; thus, the percentage of ivd200 = 0. The mean ivd of host
tissue was 35 ± 21 jm, which was much smaller than the mean
ivds per tumour for both lines, which varied between 102 ±
255 jm (E98, no. 6) and 526 ± 613 jm (E49, no. 23) (Figure 3). In
skeletal muscle ofthe hind limb, the mean arealoo was 0.07 ± 0.02
(-) and is smaller than the mean area,00 values found for the
tumour lines E49 and E98, which varied between 0.09 ± 0.02
(E98, no. 1 and no. 6) and 0.84 ± 0.02 (E49, no. 23) (Figure 5).
Vascular morphometrical analysis of perfused vessels
and 31P-MRS
The integral of the peaks in the 3'P-MR spectra reflects the quan-
tity of phosphorylated metabolites (a, P, y-NTP, Pi, PCr, PME,
PDE) in viable tumour cells (Tozer and Griffiths, 1992), in the
volume sampled by the solenoid (approximate tumour volume).
The P-/NTP ratio is accepted as an indication of the energy status
of cells (Rofstad et al, 1988; Vaupel et al, 1989a), where NTP is
broken down to NDP and P, by the action of NTPases during
cellular activities.
There was little or no contamination by PCr and NTP signals
from muscle tissue. 31P-MR spectra of tumours with similar
weights showed PCr peaks smaller than NTP peaks, except some
well-perfused tumours, e.g. E98 no. 15 (Figure 1). An example of
the domain analysis for two different tumour sections ofE49 no. 4
and E98 no. 15 is shown in Figure IA and C with the corres-
ponding 31P-MR spectra ofthe whole tumours (Figure lB and 2D).
Tumour E49 no. 4 showed a large non-perfused area in the centre,
whereas tumour E98 no. 15 showed a homogeneously perfused
vessel distribution. The tumours had the following values for the
morphometrical parameters: no. 4, percentage ofivd200 = 22, mean
area,0, = 0.52 ± 0.07; no. 15, percentage ofivd200 = 7 and mean
area,0, = 0.12 ± 0.04. The Pi/NTP ratio of no. 4, i.e. 0.45, was
higher than the ratio of no. 15, i.e. 0.17.
P/NTP ratio and the mean intervascular distance
Figure 2 shows that a frequency distribution of ivds in tumour
tissue is not a normal distribution. An important tail of large ivds
(> 200 jim) was found in all tumours (results not shown here).
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Figure 5 Plot of the correlation between the P,/NTP ratio (-) and the mean
areal00 (-) for the tumour lines E49 (EZ) and E98 (-). The line indicates the
results of least-squares linear regression analysis (R2 = 0.76) of the data for
the tumour lines E49 (E), E98 (U): y= 0.17 ± 0.03 + 0.59 ± 0.07 * x. The
dashed line shows the 95% confidence intervals. One square represents one
tumour. The Pi/NTP ratio (A) for the host tissue (skeletal muscle hind limb) is
0.09 + 0.01 and the area1 = 0.07 ± 0.02. The datapoint of the host tissue
was not used in the regression analysis
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Figure 6 Plot of the relative values of the Po2 (%) (-A-) and [glucose] (%)
(-A-) in glioma tissue (y-axis) and their Krogh radii r(x-axis) for one perfused
vessel (x = 0) calculated with use of the following parameters: Oxygen
(Kallinowski et al, 1987; Groebe et al, 1988; Dewhirst et al, 1994): mean Po2
= approximately 70 mmHg (mean Po2 vessel), mean consumption rate
gliomas (Vaupel et al, 1989b): 0.011 ml g-1 min-', radius of tissue cylinder:
0.0105 cm, Krogh's diffusion constant: 2.5 x 10- ml cm-' min-' mmHg.
Glucose (Vaupel, 1974; Kallinowski et al, 1987): mean [glucose]:
approximately 5.5 x 10-3 mmol ml-', mean consumption rate gliomas: 5 x
10-4 mmol g-1 min-', radius of tissue cylinder: 0.031 cm, diffusion coefficient:
1.2 x 10-4 cm2 min-'. For both calculations the mean radius of vessels is 4 ,um
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Standard deviations were mostly larger than mean ivds, with the
exception of most E98 tumours, which showed a more homo-
geneously perfused vessel distribution. Therefore, the mean ivd
can only be used as a rough indication for differences in the ivd
distribution between tumours. In Figure 3, the mean ivd per
tumour for both lines is related to the P1/NTP ratio. The P./NTP
ratio showed the largest changes between a mean ivd of approxi-
mately 100 gm and approximately 300 jm; the P./NTP ratio
increased around a mean ivd ofapproximately 200 ,um.
P/NTP ratio and the percentage intervascular distance
greater than 200 ,um
In Figure 4, the relationship between the P/NTP ratio and the
percentage ofivd200 is shown for the tumour lines E49 and E98. A
linear relationship was found with a goodness of fit (R2) = 0.70.
The slope of the regression lines from both tumour lines were not
significantly different (P > 0.01). The pooled slope was signifi-
cantly different from zero (P < 0.0001). No relationship was found
between the P/NTP ratio and the percentage ofivds > 100 jm and
the percentage of ivds > 300 jim (results not shown here). The
PI/NTP ratio for the host tissue (hind limb skeletal muscle) was
0.09 ± 0.01 and the percentage ofivd200 = 0. The datapoint of the
host tissue is depicted in Figure 4, but was not used in the regres-
sion analysis. The energy metabolism in muscle tissue cells prob-
ably differs from the energy metabolism in glioma tumour cells, so
a direct comparison is not allowed.
P,/NTP ratio and the non-perfused area fraction at a
distance larger than 100 jim from the nearest perfused
vessel (area100)
In Figure 5, the relationship between the PJ/NTP ratio and the
mean area,oo is shown. For both tumour lines, there was a linear
relation between the P/NTP ratio and the areaioo: R2= 0.76. The
slopes of the linear regression lines of the tumour lines E49 and
E98 were not significantly different (P > 0.01), but the pooled
slope was significantly different from zero (P < 0.0001). No rela-
tionship was found between the Pi/NTP ratio and the mean area50
and the mean area150, as expected from the results obtained for ivds
as shown in the previous paragraph. The goodness of fit in Figure
5 was slightly better than in Figure 4, i.e. the morphometrical para-
meter mean areaioo showed a better correlation with the P1/NTP
ratio than the percentage ofivd2,. The datapoint of the host tissue
was lower than the datapoints ofthe different tumours and was not
used in the regression analysis (see previous paragraph).
pHmrs and morphometrical analysis of perfused vessels
pHmrs (approximate pHi) was independent of the percentage of
ivd200 and the areaioo over a large range of values (results not
shown). All tumours showed a single PI peak corresponding to
pHns values from about neutral (pH approximately 7.0 ± 0.1) to
basic (pH approximately 7.3 ± 0.1). There were two exceptions in
the E49 line: tumour no. 16 showed a splitP, peak, corresponding
to pH values of 7.3 ± 0.2 and 6.8 ± 0.1; tumour no. 23 had pH Mrs
values of 7.12 ± 0.1 and 6.7 ± 0.1. The tumours had the following
values for the morphometric parameters: no. 16, percentage of
ivd200 = 37, meanarea1oo = 0.63 ± 0.19; no. 23, percentage ofivd200
= 43 and meanarea100 = 0.84± 0.1.
DISCUSSION
The relationship between the P1/NTP ratio and the
morphometrical parameters
In this study, the perfused vascular architecture ofcomplete trans-
verse tumour sections was analysed by two-dimensional morpho-
metric analysis. Two morphometric parameters were evaluated: (a)
the percentage of large intervascular distances and (b) the non-
perfused area fraction. These were compared with the bioenergetic
status ofthe whole tumour. To our knowledge this is the first study
that has related morphometric analysis of the perfused vascular
architecture directly to the global bioenergetic status of the same
tumour, measured by 31P-MRS.
A domain analysis was used for the calculation of intervascular
distances. A domain included non-perfused vascular structures and
avascular regions. Polymer infusion techniques can provide similar
morphometric information about ivds, but only ofperfused regions
(Less et al, 1991). Morphometric analysis of only well-perfused
regions will probably fail to correlate with the bioenergetic status
ofthe whole tumour, because avascular and non-perfused vascular
regions will have a negative impact on the global bioenergetic
status ifthese regions are hypoxic and are lacking nutrients.
The total bioenergetic status(Pi/NTP ratio) of a tumour depends
on the balance between the oxygen supply and nutrient supply and
the consumption rates of the tumour cells, which is related to the
type of energy metabolism in the different tumour cells. This
balance between supply and consumption determines the critical
diffusion distances for oxygen and nutrients in tumour tissue. The
total oxygen supply and nutrient supply depends on the tumour
microcirculation and on the diffusion geometry. This study was
restricted to the analysis of the relationship between the diffusion
geometry of a tumour and its bioenergetic status. The P./NTP ratio
was found to increase rapidly between a mean ivd of approxi-
mately 100 jm and approximately 300 jim (Figure 3). This is in
agreement with preliminary histological analysis of critical
oxygen diffusion distances in tumour sections, using a bioreduc-
tive chemical probe for hypoxic cells (Hodgkiss et al, 1991). With
use of the bioreductive chemical probe NITP (N-imidazole-theo-
phylline, a generous gift from Dr R Hodgkiss, Gray Laboratory,
England) and the perfusion marker Hoechst, hypoxic areas and
perfused vessels were stained simultaneously in the same tumour
section. The distances between perfused vessels and hypoxic areas
varied from approximately 50 jm to approximately 150 jm, with
a mean distance of 113 ±46 jm. This corresponds to a mean ivd of
approximately 200 jim. The complete study will be published
separately. The mean critical oxygen diffusion distance of approx-
imately 100 jm was used as a cut-offvalue in the definition ofthe
morphometrical parameters, i.e. the percentage of ivds > 200 jim
(ivd200) and the non-perfused area fraction at a distance > 100 jm
from the nearest perfused vessel.
At a mean distance of approximately 100 jim from a perfused
vessel, the probability of an aerobic to anaerobic transition is high.
A main question in this study was whether this transition can influ-
ence the global bioenergetic status of a tumour? Are there suffi-
cient tumour cells with an aerobic energy metabolism, depending
on oxygen for efficient NTP production or may other substrates
such as glucose assure NTP production by an intensified
(an)aerobic glycolysis?
In vitro studies on tumourcells (Pianet et al, 1991; Gerweck et al,
1993) and ex vivo studies on perfused tumours (Eskey et al, 1993)
British Journal of Cancer(1997) 75(10), 1432-1438 0Cancer Research Campaign 1997In vivo 31P-MRS and vascularity ofglioma xenografts 1437
showed the effect ofareduced oxygen supply on theoxidativephos-
phorylation ortheinhibition ofoxidative phosphorylation (Loesberg
et al, 1990). Pianet et al (1991), Gerweck et al (1993) and Eskey et
al (1993) found in vitro and ex vivo, that the reduction ofthe oxygen
tension has little influence on the NTP/P, ratio in the presence of
high glucose concentrations. They argued that (an)aerobic glyco
lysis is capable of maintaining the energy status. In vivo (DS
sarcoma), Vaupel et al (1994) reported that after reduction of the
tumour blood flow the amount of NTP remains nearly constant.
These findings were explained by an intensified glycolysis due to
the recruitment of glucose from the interstitial reservoir of the
tumour. Only for tumours with a median oxygen tension below
10-15 mmHg was NTP depletion observed. These conditions were
found for tumour masses larger than 1.5% of the body weight.
Okunieff et al (1989) observed with 31P-MRS for large tumours
(murine fibrosarcoma FSaII, approximately 2.5% of the body
weight) that i.p. injection ofglucose had a positive effect on tumour
energy metabolism, and no significant effect on the energy metabol-
ism ofsmall tumours (approximately 0.7% ofthe body weight).
What can we expect in our glioma tumour model? For a given
consumption rate and diffusion coefficient of oxygen and glucose,
critical diffusion distances can be estimatedusing the Krogh model.
The consumption rate ofoxygen andglucose is related to the energy
metabolism ofcells. Histochemical evaluation ofthis metabolism in
ratC6 gliomas (Ikezaki et al, 1992) revealed that the energy produc-
tion is more dependent on aerobic glycolysis than on oxidative
phosphorylation: enzymes of the energy-producing tricarboxylic
acidcycle and the electron-transport system were reduced, although
still present. Rhodes et al (1983) found for human gliomas in vivo,
usingpositron emission tomography (PET), a metabolic uncoupling
between the regional oxygen consumption and glucose consump-
tion. The latter is indicative of an increased aerobic glycolysis. In
order to determine the importance of the mitochondrial oxidative
phosphorylation vs aerobic glycolysis, the in vivo determination of
the oxygen and glucose consumption is important. Mean oxygen
and glucose consumption rates for macroscopic tissue volumes of
human high-grade gliomas (PET-derived data) were estimated to be
approximately 0.5 jmol g-' min-' for oxygen and approximately
0.5 ,umol g-' min-1 for glucose (Vaupel et al, 1989b). The mean
consumption rate of oxygen and glucose was found to be equal in
high-grade gliomas, which means an increased aerobic glycolytic
activity and/or an increased activity ofthe pentose phosphate shunt
for DNA synthesis (Ikezaki et al, 1992) in comparison with normal
brain tissue.
Rough estimations of the oxygen and glucose Krogh radii is
possible, using mean consumption rates, mean concentrations in
perfused vessels and constant diffusion coefficients (Figure 6). The
Krogh radii are approximately 100 gm for oxygen and approxi-
mately 200gm for glucose (Vaupel, 1974; Kallinowski et al, 1987;
Groebe, 1988; Vaupel et al, 1989b; Dewhirst et al, 1994). In vivo, a
large distribution of Krogh radii will be found, depending on: (a)
the distance in a perfused capillary from the inlet, because thepo2
and the glucose concentration in a capillary decreases between the
inlet and outlet; (b) further, the energy metabolism and the related
consumption rates of tumour cells may be heterogeneous, i.e. cell
regions with aerobic and anaerobic energy metabolism may exist.
However, the mean critical oxygen diffusion distance in Figure 6
corresponds well to the mean distance between perfused vessels
and hypoxic areas as determined by the use of the bioreductive
chemical probe NITP. In addition, the percentage ofivd200 and the
mean area.0 were linearly related to the P/NTP ratio, whereas no
relationship was found between the P/NTP ratio and higher or
lower values than the cut-off value of approximately 100 jm used
in the definition ofboth morphometrical parameters.
The results lead to thefollowinghypothesis: the linearrelationship
between the Pi/NTP ratio and the morphometrical parameters in
Figures 4 and 5 is due to a slowly changing metabolic steady
state: (aerobic) glycolysis + oxidative phosphorylation -* anaerobic
glycolysis, in which the glioma cells attempt to maintain NTP
synthesis by the anaerobic glycolysis during a progressively
decreasing glucose supply. At an intervascular distance of approxi-
mately 200jm, theprobability ofan aerobic toanaerobictransition is
high and consequently will affect the local bioenergetic status of
glioma cells, which consume oxygen. The relationships found
between the Pi/NTP ratio and the morphometrical parameters
possibly indicate that the diffusion-limited supply of oxygen is a
majordeterminantoftissueoxygenationin ourgliomatumourmodel.
As a next step, in vivo and/or in vitro measurements of the
oxygen consumption rates of tumour cells in human glioma
xenografts, used in this study, will be performed andrelated to crit-
ical diffusion distances ofoxygen in vivo.
PHmrs
Two tumours (E49, nos 16 and 23) with 36% extracellularvolume,
estimated from the eosin- and haematoxylin-stained tumour
sections, showed a split Pi peak. These tumours had the highest
values for the percentage ofivd200 andthe mean area, o. For no. 16,
the percentage ofivd200 = 37 and the mean arealo = 0.63. For no.
23, the percentage of ivd200 = 43 and the mean areaioo = 0.84.
Stubbs et al (1992) suggested that a split Pi peak is quite possible
when the contribution ofextracellular Piis 35% or more. The ApH
across the plasma membrane would have to be > 0.3-0.4 pH units.
Gerweck et al (1991) showed for murine fibrosarcoma cells
(FSaII) that the pHi is relatively resistant to changes in PHe above
6.9. Below a PHe of6.9 a pH gradient is maintained withpHibeing
consistently more basic than PHeby ± 0.35 pH units. The results of
Gerweck et al (1991) and Stubbs et al (1992) agree with our find-
ings: for tumour nos 16 and 23 the mean PHe is 6.8 ± 0.1 and 6.7 ±
0.1 and the meanpHi is 6.8 + 0.35 = 7.2 and 6.7 + 0.35 = 7.1.
No relationship was found between the pHmrs and the morpho-
metrical parameters. Spatially resolved bioluminescence and fluo-
roscopic imaging studies ofpH values in tumour tissue showed a
relationship with the distribution of perfused and non-perfused
areas (Hossmann et al, 1992), but global pHMrs measurements
failed in this study.
ABBREVIATIONS
MRS, magnetic resonance spectroscopy; ivd, intervascular
distance;ivd200,, intervasculardistance larger than 200jim; Areaiou,
non-perfused area fraction at a distance > 100 jm from a nearest
perfused vessel; NTP, nucleoside triphosphate;Pi, inorganic phos-
phate; PME, phosphomonoesters; PDE, phosphodiesters; pHmrs,
pH measured with 31P-MRS (- pH); pH, intracellular pH; pHe,
extracellular pH; po2, oxygen tension; FID, free induction decay;
PCr, phosphocreatine.
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